Related Experiment Video
Updated: Apr 27, 2026

Syntheses, Crystallization, and Spectroscopic Characterization of 3,5-Lutidine N-Oxide Dehydrate
Published on: April 24, 2018
4-isoxazolyl-1,4-dihydropyridines: a tale of two scaffolds
Nicholas R Natale1, Scott A Steiger
1Medicinal Chemistry Graduate Program, Department of Biomedical & Pharmaceutical Sciences, The University of Montana, Missoula MT 59812, USA.
Abstract:
The association of the isoxazole and dihydropyridine (DHP) ring systems fused at the 4'-isoxazolyl- to the 4-position of the DHP has produced a combination scaffold, the isoxazolyl-DHPs (IDHPs) with unique conformational characteristics. The IDHPs are useful in probing biological activity, as exemplified by our efforts in the fields of voltage gated calcium channel (VGCC) antagonists and inhibitors of the multi-drug resistance (MDR) transporter. A strategically placed methyl group produced a signifcant change at the VGCC, with (R)-(+)-1-phenyl-prop-2-yl (3.7 nM) > phenethyl (22.9 nM) > (S)-(-)-1-phenyl-prop-2-yl (210 nM), a eudismic ratio of 56.7. Branching at the C-5 of the isoxazole produced a 25% increase in MDR binding, and replacing the DHP C-3 ester with a functionalized amide also gave a dramatic increase in binding affinity. Opportunities for combined scaffolds - including examples containing IDHPs - are waiting to be discovered: because new biology is driven by new chemistry.
Related Concept Videos
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Basicity of Heterocyclic Aromatic Amines
Antihypertensive Drugs: Thiazide-Class Diuretics
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3
Five-Membered Heterocyclic Aromatic Compounds: Overview
Dipeptidyl Peptidase 4 Inhibitors

